Search

everythinglearnresearchcommunity

for

Search:↓

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

CMV infection increases the risk of GvHD after bone marrow transplants.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Tissue engineering advancements are improving skin substitutes for better burn treatment.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Autogenic PRP improves graft viability more than xenogenic PRP, but both are effective.

Choose deodorants with low allergenic ingredients and follow usage instructions to avoid skin issues.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Dermatophytes, like Trichophyton rubrum, can cause allergies and chronic inflammation.

Scalp clarifying shampoo can help reduce hair loss and improve hair volume.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.